Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.
at
Philip McGuire, F.R.C.Psych., F.Med.Sci., Philip Robson, M.R.C.P., F.R.C.Psych., Wieslaw Jerzy Cubala, M.D., Ph.D., Daniel Vasile, M.D., Ph.D., Paul Dugald Morrison, Ph.D., M.R.C.Psych., Rachel Barron, B.Vet.Med., M.R.C.V.S., Adam Taylor, Ph.D., Stephen Wright, F.R.C.P.(Edin), F.F.P.M.
Artículo Completo aqui.
Paola Cubillos M.D, N.D.
Médico Integrativo, Universidad del Rosario en Colombia.
Posgrado del Canadian College of Naturopathic Medicine en Canadá.
Vocal | Asociación Medica Colombiana de Cannabis Medicinal
